<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04784559</url>
  </required_header>
  <id_info>
    <org_study_id>APL-D-003-20</org_study_id>
    <secondary_id>2020-005951-19</secondary_id>
    <nct_id>NCT04784559</nct_id>
  </id_info>
  <brief_title>Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection</brief_title>
  <acronym>Neptuno</acronym>
  <official_title>A Phase 3, Multicentre, Randomised, Controlled Trial to Determine the Efficacy and Safety of Two Dose Levels of Plitidepsin Versus Control in Adult Patient Requiring Hospitalisation for Management of Moderate COVID-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PharmaMar</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PharmaMar</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of patients hospitalised for management of moderate COVID-19 infection&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicentre, open-label, controlled Phase 3 study in which adults requiring&#xD;
      hospital admission and O2 supplementation for management of moderate COVID-19 infection will&#xD;
      be randomised in 1:1:1 to: Plitidepsin 1.5 mg arm, Plitidepsin 2.5 mg arm and Control arm&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients Will be randomised in 1:1:1 to: Plitidepsin 1.5 mg arm, Plitidepsin 2.5 mg arm and Control arm</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients who achieve complete recovery:</measure>
    <time_frame>Day 8 (±1)</time_frame>
    <description>(i) meeting categories 0 to 2 on 11-point World Health Organization (WHO) Clinical Progression Scale, (ii) Barthel Index &gt;90/100 at the time of discharge, and (iii) with no re-admission for COVID-19-related signs or symptoms through Day 31.&#xD;
11-category WHO Clinical Progression Scale: 0. uninfected, no viral RNA detected; 1. asymptomatic, viral RNA detected and 2; symptomatic, independent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to complete recovery</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical status assessed by 11-category WHO Clinical Progression Scale:</measure>
    <time_frame>Once daily while the patient is hospitalized, Day 8 (±1), 4, 15, 31</time_frame>
    <description>0: uninfected, no viral RNA detected&#xD;
asymptomatic, viral RNA detected&#xD;
symptomatic, independent&#xD;
symptomatic, assistance needed&#xD;
hospitalised, no oxygen therapy (if hospitalised for isolation only, record status as for ambulatory patient)&#xD;
hospitalised, oxygen by mask or nasal prongs&#xD;
hospitalised, oxygen by noninvasive ventilation (NIV) or high flow&#xD;
intubation and mechanical ventilation. pO2/FIO2 ≥150 or SpO2/FIO2 ≥200&#xD;
mechanical ventilation pO2/FIO2 &lt;150 (SpO2/FIO2 &lt;200) or vasopressors&#xD;
mechanical ventilation pO2/FIO2 &lt;150 and vasopressors, dialysis, or ECMO&#xD;
dead</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with treatment-emergent adverse events (TEAEs)</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with Grade ≥3 TEAEs</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with serious adverse events (SAEs)</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with serious adverse reactions (SARs)</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with adverse events (AEs) of special interest</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and severity of treatment emergent adverse events as per National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 criteria (CTCAE v5.0)</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring re-admission for COVID-19 signs or symptoms</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of oxygen therapy (in days)</measure>
    <time_frame>From administration date to day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring high-flow oxygen</measure>
    <time_frame>Days 4, 8, 15, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring noninvasive mechanical ventilation</measure>
    <time_frame>Days 4, 8, 15, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)</measure>
    <time_frame>Days 4, 8, 15, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring admission to Intensive Care Unit (ICU)</measure>
    <time_frame>Days 4, 8, 15, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization in ICU</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients receiving subsequent antiviral therapies or immunomodulatory drugs</measure>
    <time_frame>Days 4, 8, 15, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with nosocomial infection</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Days 4, 8, 15, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SARS-CoV-2 viral, as measured by quantitative polymerase chain reaction (qPCR) from samples of oro-nasopharyngeal exudate</measure>
    <time_frame>Day 8(+/- 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with undetectable SARS-CoV-2 viral load, as measured by qPCR from samples of oro-nasopharyngeal exudate</measure>
    <time_frame>Day 8(+/- 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory biomarker: C-reactive protein (CRP)</measure>
    <time_frame>Days 1, 2, 3, 4, 8, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory biomarker: ferritin</measure>
    <time_frame>Days 1, 2, 3, 4, 8, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory biomarker: IL-6, IL-1β, IL-10</measure>
    <time_frame>Days 1, 2, 3, 4, 8, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory biomarker: tumour necrosis factor alpha (TNFα)</measure>
    <time_frame>Days 1, 2, 3, 4, 8, and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with serologic response anti-SARS-CoV-2</measure>
    <time_frame>Day 1 and 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to therapy intensification (WHO &gt;6 [intubation] or initiation of other antiviral/immunomodulating agent)</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients requiring increased oxygen therapy on study</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of treatment emergent adverse events (TEAEs), Grade ≥3 TEAEs, serious adverse events (SAEs), deaths, TEAEs leading to premature discontinuation of study drug and adverse events (AEs) of special interest</measure>
    <time_frame>From administration date to Day 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: alanine transaminase (ALT) [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: aspartate transaminase (AST) [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: alkaline phosphatase [U/L]</measure>
    <time_frame>Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: gamma glutamyl transferase (GGT) [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: lactate dehydrogenase (LDH) [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: total bilirubin [mg/dL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: direct bilirubin [mg/dL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: lipase [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: amylase [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: glucose (fasting) (mg/dL)</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: sodium [mEq/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: potassium [mEq/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: calcium (albumin adjusted calculation) [mEq/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: magnesium [mEq/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: blood urea nitrogen (BUN) [mg/dL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: creatinine [mg/dL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: calculated creatinine clearance (Cockcroft-Gault equation) [ml/min]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: albumin [g/dL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in clinical chemistry parameter: creatine-phosphokinase (CPK) [U/L]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in Troponin (I or T according to local practice for screening)</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in Troponin T (high sensitivity)</measure>
    <time_frame>Screening (Day 0-1), Days 1, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in N-terminal pro b-type natriuretic peptide (NT-pro BNP)</measure>
    <time_frame>Screening (Day 0-1), Days 1, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in Procalcitonin</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in coagulation: D dimer</measure>
    <time_frame>Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in serological SARS CoV 2 testing: immunoglobulin [Ig]G)</measure>
    <time_frame>Day 1 and 31(+/- 3)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in hematology laboratory parameter: red blood cell (RBC) [cells10^6/µL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in hematology laboratory parameter: haemoglobin [g/dL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in hematology laboratory parameter: haematocrit [%]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in hematology laboratory parameter: white blood cell (WBC) with differential [cells10^3/µL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in hematology laboratory parameter: platelet count [cells10^3/µL]</measure>
    <time_frame>Screening (Day 0-1), Days 1, 2, 3, 4, 8, and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in vital sign: temperature [°C or °F]</measure>
    <time_frame>Screening (Day 0-1), Once daily while the patient is hospitalized, and on Days 8 and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in vital sign: sitting blood pressure [mmHg]</measure>
    <time_frame>Screening (Day 0-1), Once daily while the patient is hospitalized, and on Days 8 and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in vital sign: heart rate [beats per minute]</measure>
    <time_frame>Screening (Day 0-1), Once daily while the patient is hospitalized, and on Days 8 and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in vital sign: respiratory rate [breaths per minute]</measure>
    <time_frame>Screening (Day 0-1), Once daily while the patient is hospitalized, and on Days 8 and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in vital sign: saturation of oxygen (SpO2) at room air [%]by pulse oximetry or arterial blood gas analyses and its respective FiO2 [%]</measure>
    <time_frame>Screening (Day 0-1), Once daily while the patient is hospitalized, and on Days 8 and 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in electrocardiogram (ECG) findings: QTcF prolongation</measure>
    <time_frame>Screening (Day 0-1), Day, 1, Day 3 (postinfusion) and Day 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in electrocardiogram (ECG) findings: any QTcF values &gt;500 msec</measure>
    <time_frame>Screening (Day 0-1), Day, 1, Day 3 (postinfusion) and Day 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in electrocardiogram (ECG) findings: QTcF interval &gt;30 msec</measure>
    <time_frame>Screening (Day 0-1), Day, 1, Day 3 (postinfusion) and Day 31</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Change from baseline in electrocardiogram (ECG) findings: heart rate</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48, and 49 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Change from baseline in ECG findings: QTc</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48 and 49 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Change from baseline in ECG findings: QRS</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48, and 49 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Change from baseline in ECG findings: waveform morphology-related measurements</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48, and 49 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Change from baseline in ECG findings: QTc for whole blood concentrations of plitidepsin (ng/ml)</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48, and 49 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Whole blood clearance of plitidepsin</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48, 49 and 72 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Substudy only: Whole blood area under curve (AUC) of plitidepsin</measure>
    <time_frame>0, 1, 2.5, 5, 24, 25, 26.5, 29, 48, 49 and 72 hours</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">609</enrollment>
  <condition>COVID-19 Infection</condition>
  <arm_group>
    <arm_group_label>Plitidepsin 1.5 mg arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive plitidepsin 1.5 mg/day intravenous (IV) combined with dexamethasone phosphate 8 mg/day (equivalent to 6.6 mg dexamethasone base) IV on Days 1 to 3, followed by dexamethasone phosphate 7.2 mg (equivalent to 6 mg/day dexamethasone base) oral administration (PO)/IV from Day 4 and up to a total cumulative dose of 60 mg of dexamethasone base (as per physician judgement according to patient clinical condition and evolution).&#xD;
The study allows up to a total cumulative dose of 60 mg of dexamethasone base (calculation of the total dose will also include corticosteroids administered within 72 hours before the start of the study treatment and dexamethasone administered as premedication).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plitidepsin 2.5 mg arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive plitidepsin 2.5 mg/day intravenous (IV) combined with dexamethasone phosphate 8 mg/day (equivalent to 6.6 mg dexamethasone base) IV on Days 1 to 3, followed by dexamethasone phosphate 7.2 mg (equivalent to 6 mg/day dexamethasone base) from Day 4 and up to a total cumulative dose of 60 mg of dexamethasone base (as per physician judgement according to patient clinical condition and evolution).&#xD;
The study allows up to a total cumulative dose of 60 mg of dexamethasone base (calculation of the total dose will also include corticosteroids administered within 72 hours before the start of the study treatment and dexamethasone administered as premedication).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone phosphate 8 mg/day (equivalent to 6.6 mg dexamethasone base) IV on Days 1 to 3, followed by dexamethasone phosphate 7.2 mg (equivalent to 6 mg/day dexamethasone base) from Day 4 and up to a total cumulative dose of 60 mg of dexamethasone base (as per physician judgement according to patient clinical condition and evolution). Per local treatment guidelines, patients may receive a regulatory approved antiviral treatment, such as remdesivir (200 mg IV on Day 1 followed by 100 mg/day IV on Days 2 to 5) or favipiravir (1600 mg twice daily [BID] PO on Day 1, followed by 600 mg BID PO daily for 2 to 5 days). Antiviral to be used per approved product information in each country, different dosages could be used.&#xD;
The study allows up to a total cumulative dose of 60 mg of dexamethasone base (calculation of the total dose will also include corticosteroids administered within 72 hours before the start of the study treatment and dexamethasone administered as premedication).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Plitidepsin</intervention_name>
    <description>Plitidepsin 2 mg powder is provided as a sterile, preservative-free, and white to off-white lyophilised powder/cake comprising 2 mg plitidepsin and 100 mg mannitol in a single-dose, 10 mL clear type 1 glass vial.&#xD;
Solvent for plitidepsin is provided as a sterile, preservative-free, clear, slightly viscous aqueous liquid (4 mL) containing 0.15 mL macrogolglycerol ricinoleate and 0.15 mL/mL ethanol in a single-dose type 1 clear glass ampoule.&#xD;
For administration, vial contents are reconstituted by addition of 4 mL of solvent for plitidepsin to obtain a slightly yellowish solution containing 0.5 mg/mL plitidepsin with mannitol, macrogolglycerol ricinoleate and ethanol excipients. The required amount of plitidepsin reconstituted solution is added to an IV bag containing 0.9% sodium chloride injection or 5% glucose for injection and administered as an intravenous infusion over 60 minutes.</description>
    <arm_group_label>Plitidepsin 1.5 mg arm</arm_group_label>
    <arm_group_label>Plitidepsin 2.5 mg arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Detailed information about the formulation, packaging and labelling, storage, and manufacturer is provided in the current country-specific product information. The summary of product characteristics (SmPC) and/or leaflet provides detailed product information for investigators in the European Union and/or in other regions.</description>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_label>Plitidepsin 1.5 mg arm</arm_group_label>
    <arm_group_label>Plitidepsin 2.5 mg arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remdesivir</intervention_name>
    <description>Detailed information about the formulation, packaging and labelling, storage, and manufacturer is provided in the current country-specific product information. The summary of product characteristics (SmPC) and/or leaflet provides detailed product information for investigators in the European Union and/or in other regions.</description>
    <arm_group_label>Control arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Favipiravir</intervention_name>
    <description>Detailed information about the formulation, packaging and labelling, storage, and manufacturer is provided in the current country-specific product information. The summary of product characteristics (SmPC) and/or leaflet provides detailed product information for investigators in the European Union and/or in other regions.</description>
    <arm_group_label>Control arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Signed informed consent obtained prior to initiation of any study-specific procedures&#xD;
             and study treatment&#xD;
&#xD;
          2. Documented diagnosis of SARS-CoV-2 infection, determined by either qualitative&#xD;
             polymerase chain reaction (PCR) or antigen test by local laboratory, from oro&#xD;
             nasopharyngeal exudate collected no more than 72 hours prior to study treatment on Day&#xD;
             1&#xD;
&#xD;
          3. Patient meets category 5 on the 11-point WHO Clinical Progression Scale: requires&#xD;
             hospitalization and oxygen by mask or nasal prongs/cannula&#xD;
&#xD;
          4. A maximum of 10 days from onset of COVID-19 symptoms to initiation of study treatment&#xD;
             on Day 1&#xD;
&#xD;
          5. Male or female aged ≥18 years&#xD;
&#xD;
          6. Adequate bone marrow, liver, kidney, and metabolic function, defined by the following&#xD;
             tests performed at local laboratory:&#xD;
&#xD;
               -  Absolute neutrophil count ≥1000/mm^3 (1.0 x 10^9/L)&#xD;
&#xD;
               -  Lymphocyte count ≥500/mm^3 (0.5 x 10^9/L)&#xD;
&#xD;
               -  Platelet count ≥100 000/mm^3 (100 x 10^9/L)&#xD;
&#xD;
               -  Haemoglobin &gt;9.0 g/dL&#xD;
&#xD;
               -  Alanine transaminase (ALT), aspartate transaminase (AST) ≤3 x upper limit of&#xD;
                  normal (ULN)&#xD;
&#xD;
               -  Serum bilirubin ≤1 x ULN&#xD;
&#xD;
               -  Calculated creatinine clearance ≥30 mL/min (Cockcroft and Gault formula)&#xD;
&#xD;
               -  Creatine phosphokinase ≤2.5 x ULN except if the patient has had recent (ie, in&#xD;
                  the last week) shivering episodes or trauma. In that case, the level of creatine&#xD;
                  phosphokinase (CPK) should be ≤5 x ULN).&#xD;
&#xD;
          7. Agree not to participate in another interventional clinical trial through Day 31&#xD;
&#xD;
          8. Females of reproductive capacity must have a negative serum or urine pregnancy test by&#xD;
             local laboratory at study enrolment and must be non-lactating&#xD;
&#xD;
          9. Females and males with partners of child-bearing potential must use effective&#xD;
             contraception while on study treatment and for 6 months after last dose of&#xD;
             plitidepsin. Patients in the control arm must use effective contraception at the time&#xD;
             indicated in the approved product information (summary of product characteristics&#xD;
             [SmPC] or leaflet). If no information is available in the approved product&#xD;
             information, patients in the control arm must use effective contraception for at least&#xD;
             one week after the study completion or the time indicated based on the investigator's&#xD;
             discretion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects with a pre-baseline (ie, in the prior month) impairment in general health&#xD;
             condition for whatever reason except COVID 19, requiring either assistance for daily&#xD;
             living activities (Barthel index &lt;90/100) or chronic oxygen therapy&#xD;
&#xD;
          2. Having received treatment for COVID 19 in another clinical trial in the prior 4 weeks,&#xD;
             except documented allocation in a placebo arm.&#xD;
&#xD;
          3. Evidence of respiratory failure at the time of randomisation, based on resource&#xD;
             utilisation requiring at least one of the following: endotracheal intubation and&#xD;
             mechanical ventilation, oxygen delivered by high-flow nasal cannula, noninvasive&#xD;
             positive pressure ventilation, ECMO, or clinical diagnosis of respiratory failure (ie,&#xD;
             clinical need for one of the preceding therapies, but preceding therapies not able to&#xD;
             be administered in setting of resource limitation)&#xD;
&#xD;
          4. Patients with severe COVID 19, meeting score &gt;5 on the 11 point WHO Clinical&#xD;
             Progression Scale or presenting during the screening any of clinical signs indicative&#xD;
             of severe systemic illness, such as respiratory rate ≥30 per minute, heart rate ≥125&#xD;
             per minute, or PaO2/FiO2 &lt;300&#xD;
&#xD;
          5. Patients receiving treatment with antiviral therapy against SARS-CoV-2 (either small&#xD;
             molecules or antibodies, convalescent plasma, monoclonal antibodies, IL 6 receptor&#xD;
             inhibitor, or immunomodulatory drugs) within 2 weeks before enrolment. Prior&#xD;
             administration of dexamethasone or equivalent glucocorticoid might be acceptable if:&#xD;
&#xD;
               1. The total daily dose is not higher than 6 mg of dexamethasone base (equivalent to&#xD;
                  dexamethasone phosphate 7.2 mg/day) or equivalent glucocorticoid&#xD;
&#xD;
               2. The duration of the treatment does not exceed 72 hours prior to study treatment&#xD;
                  Day 1&#xD;
&#xD;
          6. History of live vaccination within the last 4 weeks prior to study enrolment.&#xD;
             Regulatory approved, nonreplicative viral vector based vaccines are allowed if given&#xD;
             not earlier than 1 week previous to Day 1.&#xD;
&#xD;
          7. Patients receiving treatment with chloroquine or derivatives within 8 weeks before&#xD;
             enrolment or during the study&#xD;
&#xD;
          8. Patients receiving treatment with strong cytochrome P450 3A4 ( CYP3A4) inhibitors or&#xD;
             inducers&#xD;
&#xD;
          9. Viral illness (other than COVID 19) requiring therapy, except for patients with&#xD;
             treated and adequately controlled (undetectable) human immunodeficiency virus&#xD;
             infection&#xD;
&#xD;
         10. Patients with uncontrolled known primary or secondary immunodeficiency, including&#xD;
             chronic treatment with glucocorticoids (ie, prednisone at a daily dose of &gt;10 mg for&#xD;
             &gt;1 month, or other glucocorticoid at equipotent dose)&#xD;
&#xD;
         11. Any of the following cardiac conditions or risk factors:&#xD;
&#xD;
               -  Sinus bradycardia (&lt;50 beats/min), sinus nodal dysfunction (sick sinus disease),&#xD;
                  atrioventricular block of any degree (PR &gt;200 msec), or any other bradyarrhythmia&#xD;
                  (&lt;50 beats/min), except for patients with permanent pacemakers;&#xD;
&#xD;
               -  Cardiac infarction, cardiac surgery or cardiac insufficiency episode within the&#xD;
                  last 6 months;&#xD;
&#xD;
               -  Known abnormal value of left ventricular ejection fraction (LVEF &lt; LLN), unless&#xD;
                  documented confirmation of recovery (LVEF &gt; LLN) in the previous month;&#xD;
&#xD;
               -  QT interval corrected using Fridericia's formula (QTcF) &gt;450 msec for males or&#xD;
                  &gt;470 msec for females, based on triplicate 12-lead ECG at screening&#xD;
&#xD;
               -  History of known congenital or acquired QT prolongation&#xD;
&#xD;
               -  Uncorrected hypokalaemia, hypocalcaemia (adjusted), and/or hypomagnesemia at&#xD;
                  screening&#xD;
&#xD;
               -  Concomitant treatments with drugs known to be associated with a risk of QT&#xD;
                  prolongation or cardiac arrhythmia&#xD;
&#xD;
               -  Troponin test performed at local laboratory &gt; 1.5 x ULN&#xD;
&#xD;
         12. Pre-existing neuropathies of any type Grade ≥2 according to National Cancer Institute&#xD;
             Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0&#xD;
&#xD;
         13. Hypersensitivity to the active ingredient or any of the excipients (mannitol,&#xD;
             macrogolglycerol hydroxystearate, and ethanol)&#xD;
&#xD;
         14. Females who are pregnant (negative serum or urine pregnancy test required for all&#xD;
             females of child-bearing potential at screening) or breast feeding&#xD;
&#xD;
         15. Females and males with partners of child-bearing potential (females who are not&#xD;
             surgically sterile or postmenopausal defined as amenorrhoea for &gt;12 months) who are&#xD;
             not using at least 1 protocol-specified method of contraception&#xD;
&#xD;
         16. Any other clinically significant medical condition or laboratory abnormality that, in&#xD;
             the opinion of the investigator, would jeopardise the safety of the patient or&#xD;
             potentially impact patient compliance or the safety/efficacy observations in the&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José Jimeno Doñaque, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PharmaMar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>José Jimeno Doñaque, MD, PhD</last_name>
    <phone>+34918466000</phone>
    <email>clinicaltrials@pharmamar.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto Medico Platense S.A.</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Analia Mykietiuk</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Privada Monte Grande S.A</name>
      <address>
        <city>Monte Grande</city>
        <state>Buenos Aires</state>
        <zip>1842</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xavier Bocca Ruiz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Central S.A.</name>
      <address>
        <city>Villa Regina</city>
        <state>Rio Negro</state>
        <zip>8336</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Horacio Ariza</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanatorio Parque - Rosario</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luciano Lovesio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Agudos Ignacio</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1428 CABA</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ricardo Teijerio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Francisco Muñiz</name>
      <address>
        <city>Ciudad autónoma de Buenos Aires</city>
        <zip>C1282AEN CABA</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rubén Solari</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Rawson</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorena Ravera</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital São Rafael</name>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <zip>41253-190</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rogerio Passos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chronos Pesquisa Clínica</name>
      <address>
        <city>Brasília</city>
        <state>DF</state>
        <zip>72145-450</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suzara Lopes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Felicio Rocho</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <zip>30110-934</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mozar de Castro Neto</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericordia de Passos</name>
      <address>
        <city>Passos</city>
        <state>MG</state>
        <zip>37902-413</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Priscila Freitas das Neves(Goncalves)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CePCLIN - Centro de Estudos e Pesquisas em Moléstias Infecciosas Ltda</name>
      <address>
        <city>Natal</city>
        <state>RN</state>
        <zip>59025-050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kleber Giovanni Luz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Moinhos de Vento (HMV)</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Regis Rosa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Dia Do Pulmão</name>
      <address>
        <city>Blumenau</city>
        <state>SC</state>
        <zip>89030-101</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marina Lima</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital São José</name>
      <address>
        <city>Criciúma</city>
        <state>SC</state>
        <zip>88801-250</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felipe Dal Pizzol (NCI)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CEMEC - Centro Multidisciplinar de Estudos Clínicos</name>
      <address>
        <city>São Bernardo Do Campo</city>
        <zip>09715-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adilson Calvacante</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment Sveta Ekaterina EAD</name>
      <address>
        <city>Dimitrovgrad</city>
        <zip>6400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Todor Atanasov</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases - Haskovo</name>
      <address>
        <city>Haskovo</city>
        <zip>6300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Veselin Kalfov</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Dr. Nikola Vasiliev&quot; AD</name>
      <address>
        <city>Kyustendil</city>
        <zip>2500</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sashka Pavlova</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy - MBAL Pleven</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aneliya Bogdanova</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>&quot;Specialised Hospital for Active Treatment for Pneumophthisiatric Diseases Dr. Dimitar Gramatikov - Ruse&quot; Ltd Department of Pneumology and Phthisiatry</name>
      <address>
        <city>Ruse</city>
        <zip>7000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Docheva</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SHATPPD Dr. Dimitar Gramatikov, Ruse Ltd.</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hristo Metev</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University First MHAT &quot;St.Yoan Krastitel&quot;-Sofia EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1142</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dinko Valev</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment ACIBADEM CITY CLINIC TOKUDA HOSPIAL</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diana Nikova</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>&quot;MHAT &quot;Sveta Anna&quot;&quot; - Sofia AD</name>
      <address>
        <city>Sofia</city>
        <zip>1570</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dimitar Raev</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CliniSalud del Sur S.A.S - Centro de Investigación</name>
      <address>
        <city>Envigado</city>
        <state>Antioquia</state>
        <zip>55422</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Garces</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Organización Clinica Bonnadona Prevenir S.A.S</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlantico</state>
        <zip>080020</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose Navarro</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clínica de la Costa Ltda.</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlántico</state>
        <zip>80020</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Patricia Iglesias Pertuz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sociedad de Cirugía de Bogotá; Hospital de San José</name>
      <address>
        <city>Bogotá</city>
        <state>Bogotá D.C.</state>
        <zip>111411</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rodolfo Eduardo Torres Serrano</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario MEDERI</name>
      <address>
        <city>Bogotá</city>
        <state>Bogotá D.C.</state>
        <zip>111911</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Guillermo Lutz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Caja de Compensacion Familiar de Caldas</name>
      <address>
        <city>Manizales</city>
        <state>Caldas</state>
        <zip>170003</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge Ivan Marin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Valence</name>
      <address>
        <city>Valence</city>
        <state>Drome</state>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Saison</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire (CHU) Dijon Bourgogne - Hopital Francois Mitterand</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Piroth</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nouvel Hôpital Civil Service des maladies infectieuses</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Kassagne</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Regional et Universitaire de Tours (CHRU Tours) - Hopital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Bernard (NCI)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Corfu General Hospital &quot;St. IRINI&quot;</name>
      <address>
        <city>Corfu</city>
        <state>Kerkira</state>
        <zip>491 00</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ilias Papanikolaou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Democritus University Hospital University General Hospital of Alexandroupolis</name>
      <address>
        <city>Alexandroupoli</city>
        <zip>68100</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Periklis Panagopoulos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelismos Hospital General Hospital of Athens Evangelismos, Intensive Care Unit</name>
      <address>
        <city>Athens</city>
        <zip>106 76</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anastasia Kotanidou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sotiria Hospital General Hospital of Chest Diseases of Athens &quot;Sotiria&quot; 3rd Department of Internal Medicine of University of Athens</name>
      <address>
        <city>Athens</city>
        <zip>115 27</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Garyfallia Poulakou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alexandra Hospital</name>
      <address>
        <city>Athens</city>
        <zip>115 28</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Meletios Dimopoulos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens &quot;Laiko&quot;, University of Athens Agiou</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nikolaos Sypsas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Attikon Hospital</name>
      <address>
        <city>Chaïdári</city>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dimitrios Boumpas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tzaneio Hospital General Hospital of Piraeus Tzaneio</name>
      <address>
        <city>Piraeus</city>
        <zip>185 36</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Styliani Gerakari</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AHEPA Hospital University General Hospital AHEPA</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Symeon Metallidis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Cardiologica Aguascalientes</name>
      <address>
        <city>Aguascalientes</city>
        <state>Ags</state>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Marquez Diaz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Médica Sur</name>
      <address>
        <city>Mexico City</city>
        <state>Cdmx</state>
        <zip>14050</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Antonio Zapata</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanatorio Palmore, A.C.</name>
      <address>
        <city>Chihuahua</city>
        <state>CHH</state>
        <zip>31020</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugo Sánchez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name>
      <address>
        <city>Mexico City</city>
        <state>DIF</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sergio Ivan Valdes Ferrer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Investigación Clínica Chapultepec</name>
      <address>
        <city>Morelia</city>
        <state>Michoacan</state>
        <zip>58260</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guillermo Priciliano Montes Garcia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universidad Autonoma de Nuevo Leon - Hospital Universitario &quot;Dr. Jose Eleuterio Gonzalez&quot;</name>
      <address>
        <city>Monterrey</city>
        <state>NL</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eduardo Pérez Alba</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Alberto Sabogal Sologuren</name>
      <address>
        <city>Bellavista</city>
        <state>Lima</state>
        <zip>Callao 2</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Enrique Hercilla Vasquez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Chancay</name>
      <address>
        <city>Chancay</city>
        <state>Lima</state>
        <zip>15131</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose Zambrano</last_name>
    </contact>
    <contact_backup>
      <last_name>Lisbeth Cahuas Villanueva</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Hipolito Unanue (HNHU)</name>
      <address>
        <city>El Agustino</city>
        <state>Lima</state>
        <zip>15007</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ricardo Sanchez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universidad Peruana Cayetano Heredia (UPCH) - Hospital Cayetano Heredia (HCH)</name>
      <address>
        <city>Lima Cercado</city>
        <state>Lima</state>
        <zip>10680</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Rafael Seas Ramos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HULC - Hospital de Curry Cabral</name>
      <address>
        <city>Lisboa</city>
        <zip>1069-166</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernando Maltez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic De Boli Infectioase Cluj-Napoca, Sectia HIV/SIDA</name>
      <address>
        <city>Cluj-Napoca</city>
        <state>Cluj</state>
        <zip>400000</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristian Jianu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Boli Infectioase Constanta</name>
      <address>
        <city>Constanţa</city>
        <state>Tomis</state>
        <zip>900709</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simona Cambrea</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institutul National De Boli Infectioase &quot;Prof. Dr. Matei Bals&quot;</name>
      <address>
        <city>Bucharest</city>
        <zip>021105</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liliana Lucia Preotescu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Boli Infectioase si Tropicale Dr. Victor Babes - Bucharest</name>
      <address>
        <city>Bucharest</city>
        <zip>030303</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simin Aysel Florescu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institutul National De Boli Infectioase &quot;Prof. Dr. Matei Bals&quot;</name>
      <address>
        <city>Bucharest</city>
        <zip>21105</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anca Streinu-Cercel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic De Boli Infectioase &quot;Sfanta Parascheva&quot; IASI, Sectia Boli Infectioase III</name>
      <address>
        <city>Iaşi</city>
        <zip>700116</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mihaela Catalina Luca</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Judetean de Urgenta 'Sf. Ioan cel Nou' Suceava, Sectia de Boli Infectioase</name>
      <address>
        <city>Suceava</city>
        <zip>720237</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Caliman-Sturdza</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Netcare Lakeview Hospital</name>
      <address>
        <city>Benoni</city>
        <state>Gauteng</state>
        <zip>1500</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nazreen Jeewa Hussen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tiervlei Trial Centre</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7530</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthys Basson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>TASK eden</name>
      <address>
        <city>George</city>
        <state>Western Cape</state>
        <zip>6530</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kirsten McHarry</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Paredes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Molina</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerto Real</name>
      <address>
        <city>Puerto Real</city>
        <state>Cádiz.Spain</state>
        <zip>11510</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alberto Romero-Palacios</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Jerez de la Frontera</name>
      <address>
        <city>Jerez De La Frontera</city>
        <state>Cádiz</state>
        <zip>11407</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paula García Ocaña</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario HM Montepríncipe</name>
      <address>
        <city>Boadilla Del Monte</city>
        <state>Madrid</state>
        <zip>28668</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Barberan Lopez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Fuenlabrada</name>
      <address>
        <city>Fuenlabrada</city>
        <state>Madrid</state>
        <zip>28942</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge Marrero Frances</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Vates Gómez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HM Puerta del Sur</name>
      <address>
        <city>Móstoles</city>
        <state>Madrid</state>
        <zip>28038</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Castro Iglesias</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Móstoles</name>
      <address>
        <city>Móstoles</city>
        <state>Madrid</state>
        <zip>28935</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Monero Cuerda</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Quirónsalud Madrid</name>
      <address>
        <city>Pozuelo De Alarcón</city>
        <state>Madrid</state>
        <zip>28223</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Guisado Vasco</last_name>
    </contact>
    <contact_backup>
      <last_name>Ana Roda</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HM Torrelodones</name>
      <address>
        <city>Torrelodones</city>
        <state>Madrid</state>
        <zip>28250</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Villarreal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Costa Del Sol</name>
      <address>
        <city>Marbella</city>
        <state>Málaga</state>
        <zip>29603</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julian Olalla</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Quirón Marbella</name>
      <address>
        <city>Marbella</city>
        <state>Málaga</state>
        <zip>29603</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José María Ignacio García</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Álvaro Cunqueiro</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36213</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Teresa Perez-Rodriguez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces</name>
      <address>
        <city>Barakaldo</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ane Josune Goikoetxea Agirre</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>3010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esperanza Merino</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de Burgos - Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <zip>9006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Buzon Martin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universidad de Cadiz (UCA) - Hospital Universitario Puerta del Mar (HUPM)</name>
      <address>
        <city>Cadiz</city>
        <zip>11009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose Giron-Gonzalez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves (HUVN)</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen Hidalgo-Tenorio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Cecilio</name>
      <address>
        <city>Granada</city>
        <zip>18016</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Hernandez Quero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Guadalajara</name>
      <address>
        <city>Guadalajara</city>
        <zip>19002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Torralba</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Arnau de Vilanova de Lleida</name>
      <address>
        <city>Lleida</city>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfredo Jover</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U. La Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julio Ancochea</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Muñoz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Moncloa</name>
      <address>
        <city>Madrid</city>
        <zip>28008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Zarco Alonso</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <zip>28032</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Ryan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesús Fortun-Abete</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Gorgolas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente Estrada</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital 12 Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristina De La Calle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. HM Sanchinarro</name>
      <address>
        <city>Madrid</city>
        <zip>28050</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Villares</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Emergencias Enfermera Isabel Zendal</name>
      <address>
        <city>Madrid</city>
        <zip>28055</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Landete</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario de Pontevedra</name>
      <address>
        <city>Pontevedra</city>
        <zip>36071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adolfo Baloiro Villar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Marcos Martin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de Investigación Sanitaria Valdecilla (IDIVAL)</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Del Carmen Farina Alvarez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Miguel Cisneros</last_name>
    </contact>
    <contact_backup>
      <last_name>Inmaculada Rivas Jeremías</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ege University Medical School, Department of Infectious Diseases and Clinical Microbiology</name>
      <address>
        <city>Bornova</city>
        <state>İzmir</state>
        <zip>35040</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Husnu Pullukcu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>T.C. Saglik Bakanligi Tepecik Egitim ve Arastirma Hastanesi - Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klinigi</name>
      <address>
        <city>Konak</city>
        <state>Izmir</state>
        <zip>35040</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sukran Kose</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kocaeli Universitesi - Kocaeli Universitesi Tip Fakultesi - Kocaeli Universitesi Arastirma ve Uygulama Hastanesi</name>
      <address>
        <city>İzmit</city>
        <state>Kocaeli</state>
        <zip>41380</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sila Akhan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hacettepe University, School of Medicine</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serhat Unal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ankara City Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06200</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guner Hatice Rahmet</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Colombia</country>
    <country>France</country>
    <country>Greece</country>
    <country>Mexico</country>
    <country>Peru</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Turkey</country>
  </location_countries>
  <removed_countries>
    <country>Italy</country>
  </removed_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 4, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remdesivir</mesh_term>
    <mesh_term>Favipiravir</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

